Pathology of Granulomatous Pulmonary Diseases

Yale Rosen1

  • 1From the Department of Pathology, SUNY Downstate Health Sciences University, Brooklyn, New York.

Abstract

Insights

Diagnosing pulmonary granulomatous diseases is challenging due to nonspecific granulomas. Identifying the inciting agent is key, but often not possible, necessitating multidisciplinary approaches for accurate diagnosis.

Area of Science:

  • Pulmonary Pathology
  • Granulomatous Diseases
  • Diagnostic Challenges

Background:

  • Granulomas are common in many disease categories, making pulmonary granulomatous diseases numerous and diverse.
  • The nonspecific nature of granulomas presents significant diagnostic challenges for pathologists.
  • Accurate diagnosis often relies on identifying specific inciting agents, which is not always feasible.

Purpose of the Study:

  • To provide an updated guide for the pathologic diagnosis of pulmonary granulomatous diseases.
  • To clarify common misconceptions regarding these diagnoses.
  • To emphasize the critical role of multidisciplinary collaboration in patient management.

Main Methods:

  • Comprehensive review of the pertinent medical literature.
  • Utilized PubMed search engine for literature retrieval.
  • Incorporated practical experience of the author.

Main Results:

  • The review covers a wide spectrum of granulomatous lung diseases, including infections (tuberculous and nontuberculous Mycobacterial, fungal, bacterial, parasitic), sarcoidosis, and other inflammatory and neoplastic conditions.
  • Highlights the difficulty in achieving specific diagnoses when inciting agents are not identified.
  • Underscores the geographic variations in the prevalence of diseases like sarcoidosis and infections.

Conclusions:

  • Despite diagnostic challenges, the information presented aims to aid pathologists in diagnosing granulomatous lung diseases.
  • Multidisciplinary coordination is crucial, especially when morphologic diagnosis alone is insufficient.
  • Accurate diagnosis and management require a collaborative approach between pathologists, clinicians, and other specialists.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
797
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.6K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.5K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
566